196 related articles for article (PubMed ID: 26476086)
1. Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial.
Chen LY; Bigger JT; Hickey KT; Chen H; Lopez-Jimenez C; Banerji MA; Evans G; Fleg JL; Papademetriou V; Thomas A; Woo V; Seaquist ER; Soliman EZ
Am J Hypertens; 2016 Nov; 29(11):1276-1282. PubMed ID: 26476086
[TBL] [Abstract][Full Text] [Related]
2. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC
J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182
[TBL] [Abstract][Full Text] [Related]
3. Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation.
Soliman EZ; Rahman AF; Zhang ZM; Rodriguez CJ; Chang TI; Bates JT; Ghazi L; Blackshear JL; Chonchol M; Fine LJ; Ambrosius WT; Lewis CE
Hypertension; 2020 Jun; 75(6):1491-1496. PubMed ID: 32362229
[TBL] [Abstract][Full Text] [Related]
4. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
Pinho-Gomes AC; Azevedo L; Copland E; Canoy D; Nazarzadeh M; Ramakrishnan R; Berge E; Sundström J; Kotecha D; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
PLoS Med; 2021 Jun; 18(6):e1003599. PubMed ID: 34061831
[TBL] [Abstract][Full Text] [Related]
6. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.
Soliman EZ; Byington RP; Bigger JT; Evans G; Okin PM; Goff DC; Chen H
Hypertension; 2015 Dec; 66(6):1123-9. PubMed ID: 26459421
[TBL] [Abstract][Full Text] [Related]
7. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
[TBL] [Abstract][Full Text] [Related]
8. Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT.
Tawfik YMK; Van Tassell BW; Dixon DL; Baker WL; Fanikos J; Buckley LF
Diabetes Care; 2023 Apr; 46(4):868-873. PubMed ID: 36787937
[TBL] [Abstract][Full Text] [Related]
9. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial.
Williamson JD; Launer LJ; Bryan RN; Coker LH; Lazar RM; Gerstein HC; Murray AM; Sullivan MD; Horowitz KR; Ding J; Marcovina S; Lovato L; Lovato J; Margolis KL; Davatzikos C; Barzilay J; Ginsberg HN; Linz PE; Miller ME;
JAMA Intern Med; 2014 Mar; 174(3):324-33. PubMed ID: 24493100
[TBL] [Abstract][Full Text] [Related]
10. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP.
Buckley LF; Dixon DL; Wohlford GF; Wijesinghe DS; Baker WL; Van Tassell BW
Diabetes Care; 2017 Dec; 40(12):1733-1738. PubMed ID: 28947569
[TBL] [Abstract][Full Text] [Related]
11. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA
PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268
[TBL] [Abstract][Full Text] [Related]
12. The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes.
Ilkun OL; Greene T; Cheung AK; Whelton PK; Wei G; Boucher RE; Ambrosius W; Chertow GM; Beddhu S
Diabetes Care; 2020 Aug; 43(8):1878-1884. PubMed ID: 32366577
[TBL] [Abstract][Full Text] [Related]
13. Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients.
Okin PM; Hille DA; Larstorp AC; Wachtell K; Kjeldsen SE; Dahlöf B; Devereux RB
Hypertension; 2015 Aug; 66(2):368-73. PubMed ID: 26056336
[TBL] [Abstract][Full Text] [Related]
14. Systolic Blood Pressure Time in Target Range and Incident Atrial Fibrillation in Patients With Hypertension: Insights From the SPRINT Trial.
Wang J; Jiang C; Li S; Wang Z; Wang Y; Lai Y; Wang Z; Lv W; Bai Y; Yang Z; Guo Q; Huang L; He L; Guo X; Li S; Liu N; Jiang C; Tang R; Long D; Du X; Sang C; Dong J; Ma C
Hypertension; 2023 Nov; 80(11):2306-2314. PubMed ID: 37589154
[TBL] [Abstract][Full Text] [Related]
15. Effects of intensive blood pressure lowering in patients with diabetes: A pooled analysis of the STEP and ACCORD-BP randomized trials.
Yang R; Bai J; Fang Z; Wang Y; Feng Y; Liu Y; Chi H; Deng Y; Song Q; Cai J
Diabetes Obes Metab; 2023 Mar; 25(3):796-804. PubMed ID: 36433919
[TBL] [Abstract][Full Text] [Related]
16. Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis.
J Singleton M; Y Chen L; Whalen SP; D Bhave P; H Beaty E; Yeboah J; Z Soliman E
J Atr Fibrillation; 2020 Dec; 13(4):2401. PubMed ID: 34950321
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
Dewland TA; Soliman EZ; Yamal JM; Davis BR; Alonso A; Albert CM; Simpson LM; Haywood LJ; Marcus GM
Circ Arrhythm Electrophysiol; 2017 Dec; 10(12):. PubMed ID: 29212812
[TBL] [Abstract][Full Text] [Related]
18. Incidence and Implications of Atrial Fibrillation/Flutter in Hypertension: Insights From the SPRINT Trial.
Parcha V; Patel N; Kalra R; Kim J; Gutiérrez OM; Arora G; Arora P
Hypertension; 2020 Jun; 75(6):1483-1490. PubMed ID: 32362231
[TBL] [Abstract][Full Text] [Related]
19. Effects of intensive blood pressure control on cardiovascular and cognitive outcomes in patients with atrial fibrillation: insights from the SPRINT trial.
Jiang C; Lai Y; Du X; Wang Y; Li S; He L; Hu R; Lv Q; Wu J; Feng L; Ning M; Ruan Y; Li X; Jia C; Dai W; Guo X; Jiang C; Tang R; Sang C; Long D; Arima H; Dong J; Anderson CS; Ma C
Europace; 2022 Oct; 24(10):1560-1568. PubMed ID: 35640916
[TBL] [Abstract][Full Text] [Related]
20. Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials.
Beddhu S; Greene T; Boucher R; Cushman WC; Wei G; Stoddard G; Ix JH; Chonchol M; Kramer H; Cheung AK; Kimmel PL; Whelton PK; Chertow GM
Lancet Diabetes Endocrinol; 2018 Jul; 6(7):555-563. PubMed ID: 29685860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
